Welcome to our dedicated page for HEALTHSTREAM SEC filings (Ticker: HSTM), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on HEALTHSTREAM's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time EDGAR feed updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into HEALTHSTREAM's regulatory disclosures and financial reporting.
Dimensional Fund Advisors LP, a Delaware limited partnership and registered investment adviser, reports beneficial ownership of 1,557,981 shares of HealthStream Inc common stock, representing 5.3% of the class. Dimensional has sole voting power over 1,522,834 shares and sole dispositive power over 1,557,981 shares, with no shared voting or dispositive power. All shares are owned by underlying investment funds and accounts for which Dimensional or its subsidiaries provide advisory or management services, and Dimensional states that it disclaims beneficial ownership of these securities other than for purposes of Section 13(d) of the Securities Exchange Act of 1934. The funds, rather than Dimensional, are entitled to dividends and sale proceeds, and Dimensional indicates that no single fund holds more than 5% of the class.
HEALTHSTREAM INC director Linda Rebrovick reported an open-market sale of 6,000 shares of common stock on July 6, 2026 at a price of $29.00 per share. After this transaction, she directly holds 51,329 shares of HealthStream stock. The sale was carried out under a pre-arranged Rule 10b5-1 sales plan adopted on November 21, 2025, indicating the trade was scheduled in advance rather than timed discretionarily.
HSTM submitted a Form 144 notifying the proposed sale of 6,000 shares of Common Stock. The filing lists the securities as issued under a Stock Award dated 04/26/2016. The filing also reports completed dispositions of 2,000 shares on 05/28/2026 and 2,000 shares on 06/01/2026, each showing proceeds of $50,000.00.
HealthStream Inc. director Charles Jr. Beard reported acquiring 1,249 shares of common stock through the vesting and conversion of restricted share units (RSUs). Each RSU represents the right to receive one share of common stock upon vesting. The RSUs follow a three-year vesting schedule, contingent on continued service, and will vest annually in three equal installments beginning on May 29, 2026. After this transaction, Beard directly holds 1,249 shares of common stock and 2,500 RSUs.
HEALTHSTREAM INC director Dent Thompson increased his direct equity stake through equity compensation. On June 8, 2026, he acquired 3,148 shares of common stock at $0.00 per share upon vesting and conversion of restricted share units. Following these transactions, he directly holds 139,975 common shares.
HealthStream Inc. director Amir Alex Jahangir increased his equity stake through RSU vesting. On June 8, 2026, he acquired 3,148 shares of common stock upon the exercise of restricted share units, bringing his direct common stock holdings to 6,405 shares.
The filing shows multiple RSU awards, each representing the right to receive one share of common stock upon vesting. These RSUs follow three-year vesting schedules beginning on June 6, 2024, May 30, 2025, and May 29, 2026, contingent on continued service.
HEALTHSTREAM INC director Jeffrey L. McLaren reported acquiring shares through the vesting of restricted share units (RSUs). On June 8, 2026, RSU awards vested and delivered 3,148 shares of common stock, reflecting compensation rather than open‑market buying or selling.
Following these conversions, McLaren directly holds 25,748 shares of common stock and 2,032 RSUs. Each RSU represents a contingent right to receive one share of common stock upon vesting and is subject to a three‑year vesting schedule that requires continued service, with installments beginning on specific June and May dates in 2024, 2025, and 2026.
HealthStream director Terry Allison Rappuhn acquired 3,148 shares of common stock on June 8, 2026 through the vesting of restricted share units (RSUs). After these equity awards settled, she directly held 10,391 common shares, along with multiple RSU grants that continue to vest over three-year schedules tied to continued service.
HealthStream Inc. director Linda Rebrovick received 3,148 shares of common stock at no cost on vesting of restricted share units (RSUs). This award increased her direct common stock holdings to 57,329 shares.
The filing also shows exercises of RSUs into common stock across three grants, each RSU representing the right to receive one share upon vesting under multi-year vesting schedules contingent on continued service.
HealthStream director Deborah Taylor Tate acquired 3,148 shares of common stock through the vesting and conversion of restricted share units on June 8, 2026. Following these equity award exercises, she directly owns 24,699 common shares, and the RSUs vest on three‑year schedules contingent on continued service.